Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016)
Assembly Biosciences' (ASMB) quarterly Non Operating Investment Income came in at -$1.8 million in Q4 2016, down 114.41% year-on-year from $12.2 million in Q1 2016, and down 742.63% quarter-over-quarter from $273573.0 in Q3 2016.
Assembly Biosciences (ASMB) Non Operating Investment Income (2015 - 2016) Analysis & Trends
Assembly Biosciences' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at -$1.8 million for Q4 2016.
- On a quarterly basis, Non Operating Investment Income fell 114.41% year-over-year to -$1.8 million in Q4 2016; TTM through Dec 2016 was -$1.3 million, a 54.55% decrease from a year earlier, with the FY2017 full-year figure at -$615000.0, up 46.05% from the prior year.
- Non Operating Investment Income slipped to -$1.8 million in Q4 2016 per ASMB's latest filing, from $273573.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $273573.0 in Q3 2016 and bottomed at -$1.8 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -1.76 Mn |
| Dec 31, 2016 | -1.76 Mn |
| Sep 30, 2016 | 273,573.00 |
| Sep 30, 2016 | 273,573.00 |
| Jun 30, 2016 | 142,675.00 |
| Jun 30, 2016 | 142,675.00 |
| Mar 31, 2016 | 72,090.00 |
| Mar 31, 2016 | 72,090.00 |
| Dec 31, 2015 | -819,976.00 |
| Dec 31, 2015 | -819,976.00 |
| Sep 30, 2015 | -1,609.00 |
| Sep 30, 2015 | -1,609.00 |